SIM
RGLS

Spark Investment Management’s Regulus Therapeutics RGLS Stock Holding History

Spark Investment Management’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-549
Closed -$190K – 877
2016
Q2 		$190K Buy
+549
New +$393K 0.02% 631
2013
Q3 		– Sell
-296
Closed -$347K – 584
2013
Q2 		$347K Buy
+296
New +$281K 0.09% 263

Other funds holding RGLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
SDIC
South Dakota Investment Council Sioux Falls, South Dakota $5.84B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Spark Investment Management's RGLS Position: Q3 2016 in Review

Spark Investment Management sold out of Regulus Therapeutics (RGLS) in Q3 2016, closing a stake of 549 shares — an estimated $190K sold.

Spark Investment Management first reported a position in RGLS in Q2 2013 and held it in 2 quarters. The position peaked at $347K in Q2 2013. 83 funds tracked by Wall St. Rank hold RGLS as of Q3 2016.

  • Spark Investment Management reported no remaining Regulus Therapeutics position as of Q3 2016 after selling out during the quarter.
  • Spark Investment Management sold 549 Regulus Therapeutics shares in Q3 2016, an estimated $190K.
  • Spark Investment Management first reported a position in Regulus Therapeutics in Q2 2013 and held it in 2 quarters.
  • Spark Investment Management's Regulus Therapeutics position peaked at $347K in Q2 2013.
  • 83 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q3 2016.

Based on Spark Investment Management's 13F filing for Q3 2016, filed 10 Nov 2016.